HK23378A - Antihypertensive compositions - Google Patents

Antihypertensive compositions

Info

Publication number
HK23378A
HK23378A HK233/78A HK23378A HK23378A HK 23378 A HK23378 A HK 23378A HK 233/78 A HK233/78 A HK 233/78A HK 23378 A HK23378 A HK 23378A HK 23378 A HK23378 A HK 23378A
Authority
HK
Hong Kong
Prior art keywords
antihypertensive compositions
antihypertensive
compositions
Prior art date
Application number
HK233/78A
Other languages
English (en)
Inventor
C E Nelson
Scriabine
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HK23378A publication Critical patent/HK23378A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK233/78A 1972-03-06 1978-05-04 Antihypertensive compositions HK23378A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (1)

Publication Number Publication Date
HK23378A true HK23378A (en) 1978-05-12

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
HK233/78A HK23378A (en) 1972-03-06 1978-05-04 Antihypertensive compositions

Country Status (19)

Country Link
US (1) US3833727A (sv)
AT (1) AT331966B (sv)
BE (1) BE796288A (sv)
CA (1) CA1015662A (sv)
CY (1) CY951A (sv)
DD (1) DD103559A5 (sv)
FR (1) FR2181786B1 (sv)
GB (1) GB1385648A (sv)
HK (1) HK23378A (sv)
HU (1) HU165714B (sv)
IE (1) IE37326B1 (sv)
IL (1) IL41610A (sv)
KE (1) KE2839A (sv)
LU (1) LU67144A1 (sv)
MY (1) MY7800295A (sv)
NL (1) NL176746C (sv)
PH (1) PH18901A (sv)
SE (1) SE400472B (sv)
ZA (1) ZA731505B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
AT331966B (de) 1976-09-10
US3833727A (en) 1974-09-03
KE2839A (en) 1978-05-26
IL41610A (en) 1975-08-31
DE2310836B2 (de) 1976-11-04
CA1015662A (en) 1977-08-16
AU5266273A (en) 1974-08-29
FR2181786A1 (sv) 1973-12-07
BE796288A (fr) 1973-09-05
NL176746B (nl) 1985-01-02
IE37326L (en) 1973-09-06
GB1385648A (en) 1975-02-26
PH18901A (en) 1985-10-30
DD103559A5 (sv) 1974-02-05
IE37326B1 (en) 1977-06-22
ZA731505B (en) 1974-10-30
CY951A (en) 1978-12-22
IL41610A0 (en) 1973-04-30
HU165714B (sv) 1974-10-28
SE400472B (sv) 1978-04-03
DE2310836A1 (de) 1973-09-20
NL7302728A (sv) 1973-09-10
FR2181786B1 (sv) 1976-05-14
NL176746C (nl) 1985-06-03
MY7800295A (en) 1978-12-31
ATA195873A (de) 1975-12-15
LU67144A1 (sv) 1973-09-06

Similar Documents

Publication Publication Date Title
ZA729098B (en) Improved gelatin compositions
ZA737306B (en) Flavour compositions
AU5978173A (en) Softener-detergent composition
AU5365773A (en) Cementing compositions
AU6069773A (en) Compositions
ZA729091B (en) New cement compositions
GB1412716A (en) Composition for desinsitizing colour-formers
GB1396238A (en) Photodegradable compositions
GB1365030A (en) Oral compositions
ZA734996B (en) Oral composition
AU6277273A (en) Deodoeant composition
HK23378A (en) Antihypertensive compositions
CA1001072A (en) Compositions zootechniques
AU444636B2 (en) Soil-binding compositions
CA1001920A (en) Compositions extinctrices
JPS5433505A (en) Lubricant compositions
ZA735642B (en) Diuretic composition
ZA731406B (en) New antihypertensive agents
IL42039A0 (en) Fungicidal compositions
AU5790673A (en) Composition
AU485607B2 (en) Compositions
GB1398392A (en) Copolymer compositions
PH10142A (en) Smoking compositions
AU5479773A (en) 4-piperazinyl-isoquinoline compositions
ZA72961B (en) Dental-prophylaxis composition